TY  - GEN
AU  - Jung,Sung-Hoon
AU  - Lee,Je-Jung
AU  - Kim,Won Seog
AU  - Lee,Won-Sik
AU  - Do,Young Rok
AU  - Oh,Sung Yong
AU  - Kim,Min Kyoung
AU  - Mun,Yeung-Chul
AU  - Shin,Ho-Jin
AU  - Kwak,Jae-Yong
AU  - Kang,Hye Jin
AU  - Won,Jong Ho
AU  - Kwon,Jung Hye
AU  - Park,Eunkyung
AU  - Suh,Cheolwon
AU  - Yang,Deok-Hwan
TI  - Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL)
SN  - 1600-0609
PY  - 2016///0203
KW  - Age Factors
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - adverse effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Consolidation Chemotherapy
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Induction Chemotherapy
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - diagnosis
KW  - Male
KW  - Neoplasm Staging
KW  - Prednisone
KW  - Rituximab
KW  - administration & dosage
KW  - Treatment Outcome
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/ejh.12459
ER  -